Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
Recruiting now · Phase 4 · Has a placebo group
Conditions studied: Post Operative Pain, Spinal Surgery
In brief
The investigators propose a randomized, triple-blinded (patients, investigators, outcomes assessors), placebo-controlled pilot feasibility trial (Methadone to End Narcotic Dependence, MEND trial) to assess the feasibility and safety of postoperative oral methadone in patients undergoing spine surgery and collect preliminary data to inform a larger clinical trial that will test the opioid-sparing effects of methadone at 3 months after spine surgery.
Key facts
- Study ID
- NCT07222072
- Run by
- The Cleveland Clinic
- People needed
- 120
- Starts
- 2025-11-15
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2025-12-17
Who can join
Age: 18 and older, up to 72. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult ≥ 18 years of age
- Scheduled for multilevel lumbar and/or thoracic spine fusion (primary or revision)
You may not qualify if…
- <18 or >72 Years of age
- Body Mass Index >40
- Known allergy to methadone
- Pregnant females
- Non-English-speaking patients
Where it is running
- Cleveland Clinic — Cleveland, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.